Clinical trial
Efficacy and Safety of Remote Ischemic Conditioning in the Treatment of Essential Hypertension
NCT05910242 is registered in ClinicalTrials.gov with Yi Yang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Remote Ischemic Conditioning in the Treatment of Essential Hypertension
- Lead sponsor
- Yi Yang
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 20, 2023
- Completion date
- March 6, 2024
- Enrollment
- 102 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.